Schedule 13G ownership disclosure
Keros Therapeutics Inc
Security class unavailable · CUSIP: 492327101
Event date: 2023-01-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-23-000360
- Form type
- SC 13G
- Filer
- Arkin Moshe
- CIK
- CIK 1321178
- Filed
- Feb 02, 2023
- Reporting period
- Jan 26, 2023
- Description
- Schedule 13G beneficial ownership